Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

---

Copy For Citation

Kaplan M. A., Isikdogan A., Koca D., Kucukoner M., Gumusay O., Yildiz R., ...More

BREAST CANCER, vol.21, pp.677-683, 2014 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 21
• Publication Date: 2014
• Doi Number: 10.1007/s12282-013-0441-y
• Journal Name: BREAST CANCER
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.677-683
• Eskisehir Osmangazi University Affiliated: No

Abstract

In this study, we investigated the effect of lapatinib plus capecitabine treatment in HER2-positive breast cancer patients with brain metastasis.